First name
Mary
Middle name
B
Last name
Leonard

Title

Vitamin D supplementation in children and young adults with persistent proteinuria secondary to glomerular disease.

Year of Publication

2022

Number of Pages

Date Published

07/2022

ISSN Number

1432-198X

Abstract

BACKGROUND: Vitamin D deficiency is common in glomerular disease. Supplementation may be ineffective due to ongoing urinary losses of vitamin D binding protein. We sought to determine if daily cholecalciferol supplementation would increase vitamin D concentrations in children with glomerular disease and persistent proteinuria, without adverse effects.

METHODS: Eighteen participants at least 5 years of age with primary glomerular disease and urine protein:creatinine ratio ≥ 0.5 were enrolled from four pediatric nephrology practices to receive cholecalciferol supplementation: 4,000 IU or 2,000 IU per day for serum 25 hydroxyvitamin vitamin D (25OHD) concentrations < 20 ng/mL and 20 ng/mL to < 30 ng/mL, respectively. Measures of vitamin D and mineral metabolism were obtained at baseline and weeks 6 and 12. Multivariable generalized estimating equation (GEE) regression estimated mean percent changes in serum 25OHD concentration.

RESULTS: Median baseline 25OHD was 12.8 ng/mL (IQR 9.3, 18.9) and increased to 27.8 ng/mL (20.5, 36.0) at week 6 (p < 0.001) without further significant increase at week 12. A total of 31% of participants had a level ≥ 30 ng/mL at week 12. Supplementation was stopped in two participants at week 6 for mildly elevated calcium and phosphorus, respectively, with subsequent declines in 25OHD of > 20 ng/mL. In the adjusted GEE model, 25OHD was 102% (95% CI: 64, 141) and 96% (95% CI: 51, 140) higher versus baseline at weeks 6 and 12, respectively (p < 0.001).

CONCLUSION: Cholecalciferol supplementation in vitamin D deficient children with glomerular disease and persistent proteinuria safely increases 25OHD concentration. Ideal dosing to fully replete 25OHD concentrations in this population remains unknown.

CLINICAL TRIAL: NCT01835639. A higher resolution version of the Graphical abstract is available as Supplementary information.

DOI

10.1007/s00467-022-05660-9

Alternate Title

Pediatr Nephrol

PMID

35852656
Inner Banner
Publication Image
Inner Banner
Publication Image

Title

Deficits in the Functional Muscle-Bone Unit in Youths with Fontan Physiology.

Year of Publication

2021

Number of Pages

202-207

Date Published

2021 11

ISSN Number

1097-6833

Abstract

<p><strong>OBJECTIVE: </strong>To determine whether dual energy X-ray absorptiometry (DXA), a clinically available tool, mirrors the magnitude of deficits in trabecular and cortical bone mineral density (BMD) demonstrated on peripheral quantitative computed tomography in youth with Fontan physiology.</p>

<p><strong>STUDY DESIGN: </strong>We aimed to describe DXA-derived BMD at multiple sites and to investigate the relationship between BMD and leg lean mass, a surrogate for skeletal muscle loading. Subjects with Fontan (n&nbsp;=&nbsp;46; aged 5-20&nbsp;years) underwent DXA in a cross-sectional study of growth and bone and muscle health as described previously. Data from the Bone Mineral Density in Childhood Study were used to calculate age-, sex-, and race-specific BMD z-scores of the whole body, lumbar spine, hip, femoral neck, distal one-third radius, ultradistal radius, and leg lean mass z-score (LLMZ).</p>

<p><strong>RESULTS: </strong>Fontan BMD z-scores were significantly lower than reference at all sites-whole body, -0.34&nbsp;±&nbsp;0.85 (P&nbsp;=&nbsp;.01); spine, -0.41&nbsp;±&nbsp;0.96 (P&nbsp;=&nbsp;.008); hip, -0.75&nbsp;±&nbsp;1.1 (P&nbsp;&lt;&nbsp;.001); femoral neck, -0.73&nbsp;±&nbsp;1.0 (P&nbsp;&lt;&nbsp;.001); distal one-third radius, -0.87&nbsp;±&nbsp;1.1 (P&nbsp;&lt;&nbsp;.001); and ultradistal radius. -0.92&nbsp;±&nbsp;1.03 (P&nbsp;&lt;&nbsp;.001)-as was LLMZ (-0.93&nbsp;±&nbsp;1.1; P&nbsp;&lt;&nbsp;.001). Lower LLMZ was associated with lower BMD of the whole body (R&nbsp;=&nbsp;0.40; P&nbsp;&lt;&nbsp;.001), lumbar spine (R&nbsp;=&nbsp;0.16; P&nbsp;=&nbsp;.005), total hip (R&nbsp;=&nbsp;0.32; P&nbsp;&lt;&nbsp;.001), femoral neck (R&nbsp;=&nbsp;0.47; P&nbsp;&lt;&nbsp;.001), and ultradistal radius (R&nbsp;=&nbsp;0.35; P&nbsp;&lt;&nbsp;.001).</p>

<p><strong>CONCLUSIONS: </strong>Patients with Fontan have marked deficits in both cortical (hip, distal one-third radius) and trabecular (lumbar spine, femoral neck, ultradistal radius) BMD. Lower LLMZ is associated with lower BMD and may reflect inadequate skeletal muscle loading. Interventions to increase muscle mass may improve bone accrual.</p>

DOI

10.1016/j.jpeds.2021.06.068

Alternate Title

J Pediatr

PMID

34214589
Inner Banner
Publication Image
Inner Banner
Publication Image

Title

Leg lean mass correlates with exercise systemic output in young Fontan patients.

Year of Publication

2018

Number of Pages

680-684

Date Published

2018 04

ISSN Number

1468-201X

Abstract

<p><strong>OBJECTIVE: </strong>We previously described lower leg lean mass Z-scores (LLMZ) in Fontan patients associated with worse peak oxygen consumption on metabolic exercise testing. We hypothesised that LLMZ correlates with indexed systemic flow (Qsi) and cardiac index (CI) on exercise cardiac magnetic resonance (eCMR).</p>

<p><strong>METHODS: </strong>Thirteen patients had LLM measured by dual-energy X-ray absorptiometry within mean 40 (range 0-258) days of eCMR. LLM was converted to sex and race-specific Z-scores based on healthy reference data. Ventricular volumes and flow measurements of the ascending and descending (DAO) aorta and superior vena cava (SVC) were obtained by CMR at rest and just after supine ergometer exercise to a heart rate associated with anaerobic threshold on prior exercise test. Baseline and peak exercise measures of Qsi (SVC+DAO/BSA) and CI, as well as change in Qsi and CI with exercise, were compared with LLMZ by linear regression.</p>

<p><strong>RESULTS: </strong>LLMZ was not correlated with resting flows, stroke volume or CI. There was a strong linear correlation between LLMZ and change in both CI (r=0.77, p=0.002) and Qsi (r=0.73, p=0.005) from rest to exercise. There was also a significant correlation between LLMZ and Qsi at exercise (r=0.70, p=0.008). The correlation between LLMZ and CI at exercise did not reach significance (r=0.3, p=0.07).</p>

<p><strong>CONCLUSIONS: </strong>In our cohort, there was a strong linear correlation between LLMZ and change in both CI and Qsi from rest to exercise, suggesting that Fontan patients with higher LLMZ may be better able to augment systemic output during exercise, improving performance.</p>

DOI

10.1136/heartjnl-2017-311661

Alternate Title

Heart

PMID

28988207
Inner Banner
Publication Image
Inner Banner
Publication Image

Title

Deficits in bone density and structure in children and young adults following Fontan palliation.

Year of Publication

2015

Number of Pages

12-6

Date Published

2015 Aug

ISSN Number

1873-2763

Abstract

<p><strong>BACKGROUND: </strong>Survival of patients with congenital heart disease has improved such that there are now more adults than children living with these conditions. Complex single ventricle congenital heart disease requiring Fontan palliation is associated with multiple risk factors for impaired bone accrual. Bone density and structure have not been characterized in these patients.</p>

<p><strong>METHODS: </strong>Tibia peripheral quantitative computed tomography (pQCT) was used to assess trabecular and cortical volumetric bone mineral density (vBMD), cortical dimensions, and calf muscle area in 43 Fontan participants (5-33 years old), a median of 10 years following Fontan palliation. pQCT outcomes were converted to sex- and race-specific Z-scores relative to age based on &gt;700 healthy reference participants. Cortical dimensions and muscle area were further adjusted for tibia length.</p>

<p><strong>RESULTS: </strong>Height Z-scores were lower in Fontan compared to reference participants (mean ± SD: -0.29 ± 1.00 vs. 0.25 ± 0.93, p &lt; 0.001); BMI Z-scores were similar (0.16 ± 0.88 vs. 0.35 ± 1.02, p = 0.1). Fontan participants had lower trabecular vBMD Z-scores (-0.85 ± 0.96 vs. 0.01 ± 1.02, p &lt; 0.001); cortical vBMD Z-scores were similar (-0.17 ± 0.98 vs. 0.00 ± 1.00, p = 0.27). Cortical dimensions were reduced with lower cortical area (-0.59 ± 0.84 vs. 0.00 ± 0.88, p&lt;0.001) and periosteal circumference (-0.50 ± 0.82 vs. 0.00 ± 0.84, p &lt; 0.001) Z-scores, compared to reference participants. Calf muscle area Z-scores were lower in the Fontan participants (-0.45 ± 0.98 vs. 0.00 ± 0.96, p = 0.003) and lower calf muscle area Z-scores were associated with smaller periosteal circumference Z-scores (R = 0.62, p &lt; 0.001). Musculoskeletal deficits were not associated with age, Fontan characteristics, parathyroid hormone or vitamin D levels.</p>

<p><strong>CONCLUSIONS: </strong>Children and young adults demonstrate low trabecular vBMD, cortical structure and muscle area following Fontan. Muscle deficits were associated with smaller periosteal dimensions. Future studies should determine the fracture implications of these deficits and identify interventions to promote musculoskeletal development.</p>

DOI

10.1016/j.bone.2015.04.012

Alternate Title

Bone

PMID

25882907
Inner Banner
Publication Image
Inner Banner
Publication Image

Title

Lean mass deficits, vitamin D status and exercise capacity in children and young adults after Fontan palliation.

Year of Publication

2014

Number of Pages

1702-7

Date Published

2014 Nov

ISSN Number

1468-201X

Abstract

<p><strong>OBJECTIVE: </strong>We sought to evaluate body composition in children and young adults with Fontan physiology. Leg lean mass (LM) deficits correlate with diminished exercise capacity in other populations and may contribute to exercise limitations in this cohort.</p>

<p><strong>METHODS: </strong>This cross-sectional study included whole body dual energy X-ray absorptiometry scans in 50 Fontan participants ≥5 years, and measures of peak oxygen consumption (VO2) in 28. Whole body and leg LM (a measure of skeletal muscle) were converted to sex- and race-specific Z-scores, relative to age and stature, based on 992 healthy reference participants.</p>

<p><strong>RESULTS: </strong>Median age was 11.5 (range 5.1-33.5) years at 9.3 (1.1-26.7) years from Fontan. Height Z-scores were lower in Fontan compared with reference participants (-0.47±1.08 vs 0.25±0.93, p&lt;0.0001). Body mass index Z-scores were similar (0.15±0.98 vs 0.35±1.02, p=0.18). LM Z-scores were lower in Fontan compared with reference participants (whole body LM -0.33±0.77 vs 0.00±0.74, p=0.003; leg LM -0.89±0.91 vs 0.00±0.89, p&lt;0.0001). LM Z-scores were not associated with age or Fontan characteristics. Leg LM Z-scores were lower in vitamin D deficient versus sufficient Fontan participants (-1.47±0.63 vs -0.71±0.92, p=0.01). Median per cent predicted peak VO2 was 81% (range 13%-113%) and was associated with leg LM Z-scores (r=0.54, p=0.003).</p>

<p><strong>CONCLUSIONS: </strong>Following Fontan, children and young adults are shorter than their peers and have significant LM deficits. Skeletal muscle deficits were associated with vitamin D deficiency and reduced exercise capacity. Future studies should examine the progression of these deficits to further understand the contribution of peripheral musculature to Fontan exercise capacity.</p>

DOI

10.1136/heartjnl-2014-305723

Alternate Title

Heart

PMID

24973081
Inner Banner
Publication Image
Inner Banner
Publication Image

Title

Persistent Musculoskeletal Deficits in Pediatric, Adolescent and Young Adult Survivors of Allogeneic Hematopoietic Stem-Cell Transplantation.

Year of Publication

2022

Number of Pages

Date Published

2022 Jan 25

ISSN Number

1523-4681

Abstract

<p>Allogeneic hematopoietic stem cell transplantation (alloHSCT) is a common therapy for pediatric hematologic malignancies. With improved supportive care, addressing treatment-related late effects is at the forefront of survivor long-term health and quality of life. We previously demonstrated that alloHSCT survivors had increased adiposity, decreased lean mass, and lower bone density and strength, 7 years (median) from alloHSCT compared to their healthy peers. Yet it is unknown whether these deficits persist. Our longitudinal study characterized changes in muscle and bone over a period of 3.4 (range 2.0 to 4.9) years in 47 childhood alloHSCT survivors, age 5-26 years at baseline (34% female). Tibia cortical bone geometry and volumetric density and lower leg muscle cross-sectional area (MCSA) were assessed via peripheral quantitative computed tomography (pQCT). Anthropometric and pQCT measurements were converted to age, sex, and ancestry-specific standard deviation scores, adjusted for leg length. Muscle-specific force was assessed as strength relative to MCSA adjusted for leg length (strength Z-score). Measurements were compared to a healthy reference cohort (n=921), ages 5 to 30 years (52% female). At baseline and follow up, alloHSCT survivors demonstrated lower height-, weight-, and leg length Z-scores compared to the healthy reference cohort. Deficits in MCSA, trabecular volumetric bone density, and cortical bone size and estimated strength (section modulus) were evident in survivors (all p&lt;0.05). Between the two study time points, anthropometric, muscle, and bone Z-scores did not change significantly in alloHSCT survivors. Approximately 15% and 17% of alloHSCT survivors had MCSA and section modulus Z-score less than -2.0, respectively, at baseline and follow up. Furthermore, those with a history of total body irradiation compared to those without demonstrated lower MCSA at follow up. The persistent muscle and bone deficits in pediatric alloHSCT survivors support the need for strategies to improve bone and muscle health in this at-risk population. This article is protected by copyright. All rights reserved.</p>

DOI

10.1002/jbmr.4513

Alternate Title

J Bone Miner Res

PMID

35080067
Inner Banner
Publication Image
Inner Banner
Publication Image

Title

Sarcopenic Obesity in Rheumatoid Arthritis: Prevalence and Impact on Physical Functioning.

Year of Publication

2021

Number of Pages

Date Published

2021 Sep 24

ISSN Number

1462-0332

Abstract

<p><strong>OBJECTIVE: </strong>We determined the prevalence of sarcopenic obesity in patients with rheumatoid arthritis (RA) using multiple methods and assessed associations with physical functioning.</p>

<p><strong>METHODS: </strong>This study evaluated data from three RA cohorts. Whole-body dual-energy absorptiometry (DXA) measures of appendicular lean mass index (ALMI, kg/m2) and fat mass index (FMI) were converted to age, sex, and race-specific Z-Scores and categorized using a recently validated method and compared it to a widely-used existing method. The prevalence of body composition abnormalities in RA was compared with two reference populations. In the RA cohorts, associations between body composition and change in the Health Assessment Questionnaire (HAQ) and the Short Physical Performance Battery (SPPB) in follow-up were assessed using linear and logistic regression, adjusting for age, sex, race, and study.</p>

<p><strong>RESULTS: </strong>The prevalence of low lean mass and sarcopenic obesity were higher in patients with RA (14.2; 12.6%, respectively) compared with the reference population cohorts (7-10%; 4-4.5%, respectively, all p&lt; 0.05). There was only moderate agreement among methods of sarcopenic obesity categorization (Kappa 0.45). The recently validated method categorized fewer subjects as obese, and many of these were categorized as low lean mass only. Low lean mass, obesity, and sarcopenic obesity were each associated with higher HAQ and lower SPPB at baseline and numerically greater worsening.</p>

<p><strong>CONCLUSION: </strong>RA patients had higher rates of low lean mass and sarcopenic obesity than the general population. The recently validated methods characterized body composition changes differently from traditional methods and were more strongly associated with physical function.</p>

DOI

10.1093/rheumatology/keab710

Alternate Title

Rheumatology (Oxford)

PMID

34559201
Inner Banner
Publication Image
Inner Banner
Publication Image

Title

Sarcopenia and preserved bone mineral density in paediatric survivors of high-risk neuroblastoma with growth failure.

Year of Publication

2021

Number of Pages

Date Published

2021 Jun 29

ISSN Number

2190-6009

Abstract

<p><strong>BACKGROUND: </strong>Survival from paediatric high-risk neuroblastoma (HR-NBL) has increased, but cis-retinoic acid (cis-RA), the cornerstone of HR-NBL therapy, can cause osteoporosis and premature physeal closure and is a potential threat to skeletal structure in HR-NBL survivors. Sarcopenia is associated with increased morbidity in survivors of paediatric malignancies. Low muscle mass may be associated with poor prognosis in HR-NBL patients but has not been studied in these survivors. The study objective was to assess bone density, body composition and muscle strength in HR-NBL survivors compared with controls.</p>

<p><strong>METHODS: </strong>This prospective cross-sectional study assessed areal bone mineral density (aBMD) of the whole body, lumbar spine, total hip, femoral neck, distal 1/3 and ultradistal radius and body composition (muscle and fat mass) using dual-energy X-ray absorptiometry (DXA) and lower leg muscle strength using a dynamometer. Measures expressed as sex-specific standard deviation scores (Z-scores) included aBMD (adjusted for height Z-score), bone mineral apparent density (BMAD), leg lean mass (adjusted for leg length), whole-body fat mass index (FMI) and ankle dorsiflexion peak torque adjusted for leg length (strength-Z). Muscle-specific force was assessed as strength relative to leg lean mass. Outcomes were compared between HR-NBL survivors and controls using Student's t-test or Mann-Whitney U test. Linear regression models examined correlations between DXA and dynamometer outcomes.</p>

<p><strong>RESULTS: </strong>We enrolled 20 survivors of HR-NBL treated with cis-RA [13 male; mean age: 12.4&nbsp;±&nbsp;1.6&nbsp;years; median (range) age at therapy initiation: 2.6 (0.3-9.1) years] and 20 age-, sex- and race-matched controls. Height-Z was significantly lower in HR-NBL survivors compared with controls (-1.73&nbsp;±&nbsp;1.38 vs. 0.34&nbsp;±&nbsp;1.12, P&nbsp;&lt;&nbsp;0.001). Areal BMD-Z, BMAD-Z, FMI-Z, visceral adipose tissue and subcutaneous adipose tissue were not significantly different in HR-NBL survivors compared with controls. Compared with controls, HR-NBL survivors had lower leg lean mass-Z (-1.46&nbsp;±&nbsp;1.35 vs. -&nbsp;0.17&nbsp;±&nbsp;0.84, P&nbsp;&lt;&nbsp;0.001) and strength-Z (-1.13&nbsp;±&nbsp;0.86 vs. -&nbsp;0.15&nbsp;±&nbsp;0.71, P&nbsp;&lt;&nbsp;0.001). Muscle-specific force was lower in HR-NBL survivors compared with controls (P&nbsp;&lt;&nbsp;0.05).</p>

<p><strong>CONCLUSIONS: </strong>Bone mineral density and adiposity are not severely impacted in HR-NBL survivors with growth failure, but significant sarcopenia persists years after treatment. Future studies are needed to determine if sarcopenia improves with muscle-specific interventions in this population of cancer survivors.</p>

DOI

10.1002/jcsm.12734

Alternate Title

J Cachexia Sarcopenia Muscle

PMID

34184837
Inner Banner
Publication Image
Inner Banner
Publication Image

Title

Low Muscle Density is Associated with Deteriorations in Muscle Strength and Physical Functioning in Rheumatoid Arthritis.

Year of Publication

2019

Number of Pages

Date Published

2019 Dec 16

ISSN Number

2151-4658

Abstract

<p><strong>PURPOSE: </strong>Rheumatoid arthritis (RA) is associated with low muscle density due to accumulation of intramuscular fat. This study identified predictors of changes in muscle density and determined whether low muscle density predicted changes in strength and physical function.</p>

<p><strong>METHODS: </strong>Patients with RA, ages 18-70, completed whole-body DXA and peripheral quantitative CT (pQCT) to quantify lean and fat mass indices and muscle density. Dynamometry was used to measure strength at the hand, knee, and lower leg. Disability and physical function were measured with the Health Assessment Questionnaire (HAQ) and the Short Physical Performance Battery (SPPB). Assessments were performed at baseline and at follow-up. Regression analyses assessed associations between patient characteristics, muscle density, and deteriorations in strength and function.</p>

<p><strong>RESULTS: </strong>Muscle density was assessed at baseline in 107 patients with RA. Seventy-nine (74%) returned for a follow-up assessment at a median follow-up time of 2.71 years (IQR: 2.35-3.57). Factors associated with declines in muscle density included female sex, higher disease activity, smoking, and lower IGF-1 levels. Greater muscle density Z-Score at baseline (per 1 SD) was associated with less worsening per year of HAQ, SPPB, and 4-meter walk time and a lower risk of a clinically important worsening in HAQ [OR 1.90 (1.06,3.42) p=0.03] and walking speed [OR 2.87 (1.05,7.89) p=0.04].</p>

<p><strong>CONCLUSION: </strong>Worsening of skeletal muscle density occurred in patients with higher disease activity, smokers, and those with lower IGF-1. Low muscle density was associated with worsening of physical function. Interventions addressing reductions in muscle quality might prevent functional decline.</p>

DOI

10.1002/acr.24126

Alternate Title

Arthritis Care Res (Hoboken)

PMID

31841259
Inner Banner
Publication Image
Inner Banner
Publication Image